DossierENTITY

vaccine developers

Coverage of vaccine developers in the Nexus archive.

Earliest in view: May 26 · 16:28 UTCMost recent: May 26 · 16:28 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSMay 26 · 16:28 UTCBLOOMBERG
Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion
Eli Lilly and Company is acquiring three vaccine developers for up to $3.8 billion. The transaction highlights the company's expansion into vaccine development and biotechnology innovation.